Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

Comparison of Serum Contraceptive Hormone Levels Between Normal Weight and Obese Users of the NuvaRing®

Not Applicable

Completed

Conditions: Pharmacokinetics

Interventions: Drug: NuvaRing

First Posted Date: 2008-07-04

Last Posted Date: 2015-04-30

Lead Sponsor: Columbia University

Target Recruit Count: 40

Registration Number: NCT00710606

Locations: 🇺🇸
Division of Family Planning and Preventive Services, New York, New York, United States

Feasibility of Delphi Screener for Cervical Cytology

Phase 2

Completed

Conditions: Cervical Neoplasia

Interventions: Device: Delphi Screener

First Posted Date: 2008-06-20

Last Posted Date: 2014-01-13

Lead Sponsor: Columbia University

Target Recruit Count: 198

Registration Number: NCT00702208

Locations: 🇺🇸
Columbia University Presbyterian Hospital, New York, New York, United States

Cardiovascular and Neurohormonal Effects of Faster Atrial Pacing Rate

Not Applicable

Terminated

Conditions: Heart Failure

Interventions: Device: Medtronic Pacemaker

First Posted Date: 2008-06-17

Last Posted Date: 2018-04-27

Lead Sponsor: Columbia University

Target Recruit Count: 3

Registration Number: NCT00698139

Locations: 🇺🇸
Columbia University, New York, New York, United States

Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women

Phase 2

Completed

Conditions: Menopause
Fracture
Osteoporosis

Interventions: Drug: Teriparatide (PTH 1-34)

First Posted Date: 2008-06-13

Last Posted Date: 2018-07-26

Lead Sponsor: Columbia University

Target Recruit Count: 22

Registration Number: NCT00697463

Locations: 🇺🇸
Creighton University, Omaha, Nebraska, United States
🇺🇸
Columbia University Medical Center, New York, New York, United States

Patent Foramen Ovale in Cryptogenic Stroke Study

Phase 4

Completed

Conditions: Ischemic Stroke
Patent Foramen Ovale

Interventions: Drug: Warfarin
Drug: Aspirin

First Posted Date: 2008-06-13

Last Posted Date: 2011-09-15

Lead Sponsor: Columbia University

Target Recruit Count: 630

Registration Number: NCT00697151

Locations: 🇺🇸
Columbia College of Physicians and Surgeons, New York, New York, United States

Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies

Phase 1

Completed

Conditions: Non-Hodgkin's Lymphoma
Hodgkin's Disease

Interventions: Drug: Vorinostat
Drug: Niacinamide
Drug: Etoposide

First Posted Date: 2008-06-05

Last Posted Date: 2020-11-20

Lead Sponsor: Columbia University

Target Recruit Count: 40

Registration Number: NCT00691210

Locations: 🇺🇸
Center for Lymphoid Malignancies at CUMC, New York, New York, United States

Epidural Fentanyl-bupivacaine Versus Clonidine-bupivacaine for Breakthrough Pain in Advanced Labor

Phase 4

Withdrawn

Conditions: Labor Pain

Interventions: Drug: Clonidine or fentanyl

First Posted Date: 2008-06-05

Last Posted Date: 2012-02-14

Lead Sponsor: Columbia University

Registration Number: NCT00691795

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors

Phase 1

Terminated

Conditions: Growth Hormone Deficiency

Interventions: Drug: Recombinant Human Growth Hormone
Drug: Recombinant Human IGF-1

First Posted Date: 2008-05-28

Last Posted Date: 2024-07-17

Lead Sponsor: Columbia University

Target Recruit Count: 5

Registration Number: NCT00684957

Locations: 🇺🇸
Columbia University, College of Physicians and Surgeons, New York, New York, United States

The Effects of Leucine on Body Weight

Not Applicable

Completed

Conditions: Overweight
Obesity

Interventions: Other: Liquid meal
Dietary Supplement: L-Leucine 8gr
Dietary Supplement: L-Leucine 4g

First Posted Date: 2008-05-26

Last Posted Date: 2013-03-05

Lead Sponsor: Columbia University

Target Recruit Count: 8

Registration Number: NCT00683826

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Safety and Efficacy of Conivaptan for the Correction of Hyponatremia in Neurological Patients

Phase 3

Withdrawn

Conditions: Hyponatremia

Interventions: Other: D5
Drug: Conivaptan

First Posted Date: 2008-05-26

Last Posted Date: 2015-03-06

Lead Sponsor: Columbia University

Registration Number: NCT00684164

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy